9 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
lowered CV events in T2DM ... lowered CV events in T2DM ... + T2DM; first renal ... with or without T2DM ... visualabstract #table
A1C and eAG
~
*For Educational Purposes Only*

#Diabetes #T2D #DM2 #Table #PrimaryCare #Endocrinology #BloodGlucose #A1C
#Diabetes #T2D ... #DM2 #Table #PrimaryCare
Management of Diabetes Mellitus in Patients With CKD

1. Monitor for changes in BP, serum creatinine, &
Patients With CKD ... patients with T2D ... ml/min per 1.73 m2 ... ADA/KDIGO Consensus ... ADA #KDIGO #eGFR
Estimating the Total Daily Dose (TDD) of Insulin: Weight-Based Dosing
TDD in units of insulin = N
Total Daily Dose (TDD ... (stage IV or V CKD ... Calculate TDD 2 ... Add sliding scale ... endocrinology #diabetes #DM2
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
Ozempic), or daily tablet ... patients with T2D ... Pharmacology #Summary #DM2
Algorithm for Diagnosis and Management of Resistant Hypertension in CKD
Pseudoresistant Hypertension - Reduce barriers to adherence:
Algorithm for Diagnosis ... Hypertension in CKD ... Evaluate for CKD ... 30 mL/min/1.73 m2 ... #Algorithm #Diagnosis
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
Insulin dependent DM ... ASA class If ... event, follow ACC algorithm ... Stable patients ... and undergoing AAA
Algorithm for choosing the appropriate candidate for stress testing in patients with suspected coronary artery disease
Algorithm for choosing ... artery disease (CAD ... with suspected CAD ... is based on ACC/AHA ... evaluation of stable
Hyperkalemia - Diagnosis and Management - GrepMed Handbook

S/Sx: Most pts asymptomatic. Weakness, cramping, nausea, paresthesias, palpitations,
transfusions), ↓insulin (DM ... VBG (acidosis), CK ... Elimination (see Table ... Na-Zirconium (10g PO tid